InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Explore the complete record of transactions filed by Benedicto David C., Chief Financial Officer. Director active across 1 company, notably Adamis Pharmaceuticals Corp. In total, 3 reports have been published. Split: 0 buy · 3 sells. Total volume traded: €21k. Activity tracked since 1 December 2021. The latest transaction was disclosed on 18 March 2022 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations3 total
3,603 shares@ US$0.61289.6% of flowCommon StockSEC:0001387131-22-003860:0
13,554 shares@ US$0.78545.2% of flowCommon StockSEC:0001387131-21-011778:0
13,554 shares@ US$0.785100.0% of flowCommon StockSEC:0001387131-21-011778
3 of 3 declarations
About Benedicto David C.
Benedicto David C. is the Chief Financial Officer at Adamis Pharmaceuticals Corp. He is responsible for the company's financial management, including budgeting and performance analysis, playing a key role in financial strategy.
